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Process intensification through integration of upstream perfusion cell culture with downstream
continuous chromatography in monoclonal antibody production
Andreas Castan, Thomas Falkman, Eric Fäldt, Teres Persson, Lisa Blomqvist and Annika Forss
GE Healthcare Bio-Sciences AB, Björkgatan 30, 751 84 Uppsala, Sweden
Process intensification is gaining interest as a strategy to reduce production costs, while improving product
quality and throughput in the manufacturing of biopharmaceuticals. For a competitive production process,
continuous or semi-continuous upstream and downstream processing can be employed. Compared with a
process performed in batch runs, continuous processing allows for increased capacity utilization and
eliminates or minimized the need for intermediate hold-up steps. Here, we describe the integration of a highperforming upstream cell culture process with downstream purification utilizing new emerging technologies
such as periodic counter-current (PCC) chromatography and straight-through processing (STP).
A high-cell density perfusion process based on commercially available ActiCHO™ cell culture media was
developed for a MAb-producing Chinese hamster ovary (CHO) cell line. Medium prototypes were evaluated
in small scale using the single-use ReadyToProcess WAVE™ 25 bioreactor system. Medium optimization
resulted in a final process with a cell-specific perfusion rate (CSPR) of less than 50 pL/cell/d. Process
performance was verified at laboratory scale using single-use stirred-tank bioreactor systems. Productivity
and product quality of the developed perfusion process were compared with a standard fed-batch process.
MAb capture on MabSelect SuRe™ LX protein A chromatography medium (resin) was performed in a threecolumn PCC (3C PCC) setup. The capture step was followed by two polishing steps using Capto™ S ImpAct
ion exchange and Capto adhere multimodal ion exchange media in serially connected columns in a STP
setup. MAb purity and yield of the developed continuous processes were compared with traditional setups
performed in batch runs.
In this case study, we demonstrate the feasibility of integrated upstream and downstream MAb processing
performed in a continuous manner. The developed process shows a performance equivalent to traditional
processing performed in batch runs.

